Other
Dentinal Hypersensitivity
0
Pipeline Programs↗
3
Active Trials↗
1
Companies Involved↗
Dentinal Hypersensitivity is an early-stage landscape with 0 programs across 1 company. The most active players are GSK.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
30
clinical trials
Completed26 · 87%
Not yet recruiting2 · 7%
Recruiting1 · 3%
Unknown status1 · 3%
Clinical Trials
Trial Activity
30 trials
Efficacy of a Potassium Nitrate Containing Herbal Mouthwash to a Potassium Oxalate Mouthwash in Dentinal Hypersensitivity
Recruiting·—·Phase 3·NCT06627790·40 enrolled
Comparison of LASER Therapy and Desensitizing Agents in Dentinal Hypersensitivity
Not yet recruiting·—·N/A·NCT06759454·172 enrolled
Comparative Efficacy of Laser Systems and Fluoride in Managing Dentinal Hypersensitivity: RCT
Not yet recruiting·—·N/A·NCT07141576·96 enrolled
A Clinical Study to Assess the Effects of Various Dentifrice Technologies on Dentinal Hypersensitivity
Completed·—·N/A·NCT03965039·120 enrolled
Efficacy of Herbal Dentifrice for Management of Dentinal Hypersensitivity
Completed·—·Phase 3·NCT05852366·75 enrolled
Dentinal Hypersensitivity Reduction
Completed·—·Phase 3·NCT06244290·123 enrolled
A Clinical Study of Two Dentinal Hypersensitivity Treatments Used With Normal Oral Hygiene
Completed·—·N/A·NCT02221349·30 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)